Official figures and published prices. Each figure retains its source, date and scope. Public tariffs are health-system payments, not private quotes; recorded waits do not promise a current appointment.
Care Path for India. Explore public care and possible funding before comparing private providers. Your clinician and payer decide suitability and eligibility.
Information, not medical or legal advice.
Ask local providers for a written quote for the complete episode of care.
Who can use it: Check clinical suitability and payment arrangements with the provider.
Cost to you: varies — Confirm a written patient price or funding decision.
Published waits are historical statistics, not an appointment forecast. Costs and waits are unknown unless a source is shown. Private comparisons below are in USD; official figures retain their source currency.
₹23,400 (2022): public PM-JAY treatment payment benchmark, not a self-pay patient price. Separately listed implants are excluded.
2 tariff codes at the same value
Published range: 20,000–25,000 INR across 3 city-tier observations
Source: PM-JAY · Source period: 2022 · Captured: 2026-10-14 · n=6 observationsScope: India. Payer context: Public tariff. HBP 2022 city-tier procedure tariff; separately mapped implants are excluded; state amendments/accreditation incentives not applied. Source code: SG050A. The displayed figure is the median of the eligible published tariff cells.
n=3 eligible observations. n is not a patient count. Episode equivalence: unverified.
Scope: India. Payer context: Public tariff. HBP 2022 city-tier procedure tariff; separately mapped implants are excluded; state amendments/accreditation incentives not applied. Source code: SG050B. The displayed figure is the median of the eligible published tariff cells.
n=3 eligible observations. n is not a patient count. Episode equivalence: unverified.
No eligible waiting time in this subset.
Check scope, payer, statistic, population and period. Figures may cover different services; they are not a clinical ranking.
No official figure yet. How we collect official figures
No eligible price in this subset.
103 days — average waiting time, patients still on the public waiting list
Source: Spain Ministry of Health · Source period: 2025-12-31 · Captured: 2026-10-14 · n=1 observationsScope: Spain. Population: patients still on the public waiting list. Reported statistic: average waiting time. Shown as reported by the source.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
€1,821.82 (ATIH, 2026): official public payment benchmark, not a self-pay patient price; coverage and eligibility vary.
Source: ATIH · Source period: 2026 · Captured: 2026-10-14 · n=1 observationsScope: France. Payer context: Public tariff. GHS public-sector base tariff from 2026 schedule; source DATE-EFFET retained separately. Source code: 06C12J.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
Administrative GHS baseline; group includes related procedures and may not prove all basket inclusions. Geographic/prudential adjustments, supplements and separately reimbursed devices excluded.
No eligible waiting time in this subset.
No official figure yet. How we collect official figures
No eligible price in this subset.
England: General Surgery Service (specialty-level wait, not a procedure-specific wait): 12.78 weeks — median waiting time, patients still on the public waiting list
Source: NHS England (Referral to Treatment) · Source period: August 2026 · Captured: 2026-10-14 · n=1 observationsScope: United Kingdom (England). Population: patients still on the public waiting list. Reported statistic: median waiting time. Shown as reported by the source.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
Specialty-level proxy, not a procedure waiting time. Incomplete consultant-led referral-to-treatment pathways at month end; includes diagnostics and appointments. Published NHS median/p92 are estimates from aggregate data; values are copied, never calculated from bins. One specialty is intentionally referenced by multiple basket items; do not count these as independent cohorts.
England: General Surgery Service (specialty-level wait, not a procedure-specific wait): 41.19 weeks — 92% of patients still on the public waiting list waited this long or less
Source: NHS England (Referral to Treatment) · Source period: August 2026 · Captured: 2026-10-14 · n=1 observationsScope: United Kingdom (England). Population: patients still on the public waiting list. Reported statistic: p92. Shown as reported by the source.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
Specialty-level proxy, not a procedure waiting time. Incomplete consultant-led referral-to-treatment pathways at month end; includes diagnostics and appointments. Published NHS median/p92 are estimates from aggregate data; values are copied, never calculated from bins. One specialty is intentionally referenced by multiple basket items; do not count these as independent cohorts.
Scotland: General Surgery (C1); inpatient/day-case stage of treatment; completed waits (specialty-level wait, not a procedure-specific wait): 56 days — median waiting time, patients who were treated
Source: Public Health Scotland · Source period: August 2026 · Captured: 2026-10-14 · n=1 observationsScope: United Kingdom (Scotland). Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
Published specialty-level stage-of-treatment wait, not a procedure-specific wait or full referral-to-treatment pathway. The same specialty statistic may appear for multiple basket procedures; do not count those as independent patient cohorts.
Scotland: General Surgery (C1); inpatient/day-case stage of treatment; completed waits (specialty-level wait, not a procedure-specific wait): 304.8 days — 90% of patients who were treated waited this long or less
Source: Public Health Scotland · Source period: August 2026 · Captured: 2026-10-14 · n=1 observationsScope: United Kingdom (Scotland). Population: patients who were treated. Reported statistic: p90. Shown as reported by the source.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
Published specialty-level stage-of-treatment wait, not a procedure-specific wait or full referral-to-treatment pathway. The same specialty statistic may appear for multiple basket procedures; do not count those as independent patient cohorts.
Scotland: General Surgery (C1); inpatient/day-case stage of treatment; ongoing waits (specialty-level wait, not a procedure-specific wait): 110 days — median waiting time, patients still on the public waiting list
Source: Public Health Scotland · Source period: August 2026 · Captured: 2026-10-14 · n=1 observationsScope: United Kingdom (Scotland). Population: patients still on the public waiting list. Reported statistic: median waiting time. Shown as reported by the source.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
Published specialty-level stage-of-treatment wait, not a procedure-specific wait or full referral-to-treatment pathway. The same specialty statistic may appear for multiple basket procedures; do not count those as independent patient cohorts.
Scotland: General Surgery (C1); inpatient/day-case stage of treatment; ongoing waits (specialty-level wait, not a procedure-specific wait): 310 days — 90% of patients still on the public waiting list waited this long or less
Source: Public Health Scotland · Source period: August 2026 · Captured: 2026-10-14 · n=1 observationsScope: United Kingdom (Scotland). Population: patients still on the public waiting list. Reported statistic: p90. Shown as reported by the source.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
Published specialty-level stage-of-treatment wait, not a procedure-specific wait or full referral-to-treatment pathway. The same specialty statistic may appear for multiple basket procedures; do not count those as independent patient cohorts.
US$503.49 (January 2026): Medicare doctor fee benchmark, not a complete patient bill. Hospital, anaesthesia and implant are excluded.
Source: US Medicare (CMS) · Source period: January 2026 · Captured: 2026-10-14 · n=109 observationsScope: United States. Payer context: Public tariff. PFS professional fee in facility; non-QP; excludes hospital, anaesthesia and implant. Source code: 49505. The displayed figure is the median of the eligible published tariff cells.
n=109 eligible observations. n is not a patient count. Episode equivalence: unverified.
US$421.63 (January 2026): Medicare doctor fee benchmark, not a complete patient bill. Hospital, anaesthesia and implant are excluded.
Source: US Medicare (CMS) · Source period: January 2026 · Captured: 2026-10-14 · n=109 observationsScope: United States. Payer context: Public tariff. PFS professional fee in facility; non-QP; excludes hospital, anaesthesia and implant. Source code: 49650. The displayed figure is the median of the eligible published tariff cells.
n=109 eligible observations. n is not a patient count. Episode equivalence: unverified.
US$3,657.95 (October 2026): Medicare outpatient hospital payment benchmark, not a self-pay price. The separate doctor fee is excluded.
Source: US Medicare (CMS) · Source period: October 2026 · Captured: 2026-10-14 · n=1 observationsScope: United States. Payer context: Public tariff. OPPS national unadjusted hospital outpatient facility payment; excludes separate professional fee. Source code: 49505.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
US$6,176.47 (October 2026): Medicare outpatient hospital payment benchmark, not a self-pay price. The separate doctor fee is excluded.
Source: US Medicare (CMS) · Source period: October 2026 · Captured: 2026-10-14 · n=1 observationsScope: United States. Payer context: Public tariff. OPPS national unadjusted hospital outpatient facility payment; excludes separate professional fee. Source code: 49650.
n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.
No eligible waiting time in this subset.
What to arrange if you travel for this procedure.
₹23,400 (2022): public PM-JAY treatment payment benchmark, not a self-pay patient price. Separately listed implants are excluded. Scope: HBP 2022 city-tier procedure tariff; separately mapped implants are excluded; state amendments/accreditation incentives not applied. Captured: 2026-10-14. n=3. Source: https://cdnbbsr.s3waas.gov.in/s3169779d3852b32ce8b1a1724dbf5217d/uploads/2024/06/20240619792610196.pdf.
₹23,400 (2022): public PM-JAY treatment payment benchmark, not a self-pay patient price. Separately listed implants are excluded. Scope: HBP 2022 city-tier procedure tariff; separately mapped implants are excluded; state amendments/accreditation incentives not applied. Captured: 2026-10-14. n=3. Source: https://cdnbbsr.s3waas.gov.in/s3169779d3852b32ce8b1a1724dbf5217d/uploads/2024/06/20240619792610196.pdf.